Success Stories: NIW Petition Approved for Postdoctoral Associate in the Field of Biomedical Physics

Client’s Testimonial:

Thanks a lot! […] I appreciate your help during this process.

On October 10th, 2014, We Received EB-2 NIW (National Interest Waiver) Approval (Approval Notice) for a Postdoctoral Associate in the Field of Biomedical Physics

General Field: Biomedical Physics

Position at the Time of Case Filing: Postdoctoral Associate

Service Center: Texas Service Center (TSC)

Approval Notice Date: October 10^th, 2014

Processing Time: 5 Months, 4 Days

Case Summary:

In this case we worked with a postdoctoral associate in the field of biomedical physics, and we aimed to show that his continued employment in that field would be of manifest benefit both to his colleagues and to the people of the United States as a whole. He had published 7 peer-reviewed scientific papers as well as 5 conference publications and 16 conference presentations, focusing specifically on the development of advanced biomedical imaging techniques. At the time we filed his case, his work had been cited at least 64 times by leading and independent researchers at foremost institutions around the world, demonstrating the wide recognition of and reliance upon his work in his greater academic community. Through the extensive documentation we submitted proving his highly significant contributions to the field, we were able to show that our client would serve the national interest to a significantly greater degree than others with similar educational and experiential credentials. His NIW petition was thus approved in five months and four days.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.